Introduction:Basic information about CAS 149022-22-0|Amikacin sulfate, including its chemical name, molecular formula, synonyms, physicochemical properties, and safety information, etc.
| Common Name | Amikacin sulfate |
|---|
| CAS Number | 149022-22-0 | Molecular Weight | 781.760 |
|---|
| Density | / | Boiling Point | 981.8ºC at 760mmHg |
|---|
| Molecular Formula | C22H43N5O13.9/5H2O4S | Melting Point | / |
|---|
| MSDS | ChineseUSA | Flash Point | 547.6°C |
|---|
Names
| Name | Amikacin sulfate salt |
|---|
| Synonym | More Synonyms |
|---|
Amikacin sulfate BiologicalActivity
| Description | Amikacin sulfate (BAY 41-6551 sulfate) is an aminoglycoside antibiotic and a semisynthetic analog of kanamycin. Amikacin sulfate is bactericidal, acting directly on the 30S and 50S bacerial ribosomal subunits to inhibit protein synthesis. Amikacin sulfate is very active against most Gram-negative bacteria including gentamicin- and tobramycin-resistant strains. Amikacin sulfate also inhibits the infections caused by susceptible Nocardia and nontuberculous mycobacteria[1][2]. |
|---|
| Related Catalog | Research Areas >>InfectionSignaling Pathways >>Anti-infection >>Bacterial |
|---|
| In Vitro | Amikacin offers definite advantages for treating infections caused by organisms resistant to other aminoglycosides. Amikaci is affected by relatively few arninoglycoside-modifying enzymes. Amikacin is useful in the treatment of infections caused by Nocardia asteroides, Mycobacterium avium-intracellulare, and certain species of "rapid-growing" mycobacteria (that is, M. chelonae and M. fortuitumi)[1]. Amikacin (100-1500 μM) causes a reliable dose-dependent loss of lateral line zebrafish hair cells with a LD50 value of 453 μM[3]. |
|---|
| In Vivo | Amikacin (320 mg/kg; subcutaneous injection; daily; for 10 days; male Fischer rats) treatment increases the chance of serious hearing loss in rats in vivo[3]. Animal Model: Male Fischer 344 rats (40-50-day-old)[3] Dosage: 320 mg/kg Administration: Subcutaneous injection; daily; for 10 days Result: Induced hearing loss in rats. |
|---|
| References | [1]. Edson, R.S. and C.L. Terrell, The aminoglycosides. Mayo Clin Proc, 1999. 74(5): p. 519-28. [2]. Ristuccia AM, et al. An overview of amikacin. Ther Drug Monit. 1985;7(1):12-25. [3]. Siân R Kitcher, et al. ORC-13661 Protects Sensory Hair Cells From Aminoglycoside and Cisplatin Ototoxicity. JCI Insight. 2019 Aug 8;4(15):e126764. |
|---|
Chemical & Physical Properties
| Boiling Point | 981.8ºC at 760mmHg |
|---|
| Molecular Formula | C22H43N5O13.9/5H2O4S |
|---|
| Molecular Weight | 781.760 |
|---|
| Flash Point | 547.6°C |
|---|
| Exact Mass | 781.220520 |
|---|
| PSA | 497.90000 |
|---|
| Appearance of Characters | white to off-white |
|---|
| Vapour Pressure | 0mmHg at 25°C |
|---|
| InChIKey | HIBICIOPDUTNRR-BOEHXBESSA-N |
|---|
| SMILES | NCCC(O)C(=O)NC1CC(N)C(OC2OC(CN)C(O)C(O)C2O)C(O)C1OC1OC(CO)C(O)C(N)C1O.O=S(=O)(O)O |
|---|
| Storage condition | 2-8°C |
|---|
| Water Solubility | H2O: soluble50mg/mL |
|---|
Safety Information
| Personal Protective Equipment | Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter |
|---|
| RIDADR | NONH for all modes of transport |
|---|
| WGK Germany | 2 |
|---|
| RTECS | WK1961200 |
|---|
| HS Code | 2941902000 |
|---|
Customs
Articles1
More Articles
| High content screening identifies decaprenyl-phosphoribose 2' epimerase as a target for intracellular antimycobacterial inhibitors. PLoS Pathog. 5(10) , e1000645, (2009) A critical feature of Mycobacterium tuberculosis, the causative agent of human tuberculosis (TB), is its ability to survive and multiply within macrophages, making these host cells an ideal niche for ... | |
Synonyms
| AMIKACIN SULFATE 1:1.8 |
| Butanamide, 4-amino-N-[(1R,2S,3S,4R,5S)-5-amino-2-[(3-amino-3-deoxy-α-D-glucopyranosyl)oxy]-4-[(6-amino-6-deoxy-α-D-glucopyranosyl)oxy]-3-hydroxycyclohexyl]-2-hydroxy-, (2S)-, sulfate (1:2) (s alt) |
| (2S)-4-Amino-N-{(1R,2S,3S,4R,5S)-5-amino-2-[(3-amino-3-deoxy-α-D-glucopyranosyl)oxy]-4-[(6-amino-6-deoxy-α-D-glucopyranosyl)oxy]-3-hydroxycyclohexyl}-2-hydroxybutanamide sulfate (1:2) |
| amikacin sulphate |